HCPCS code J1302 — Inj, sutimlimab-jome, 10 mg. Status: Active. Effective Oct 1, 2022. Source: CMS HCPCS Level II.

J1302

Active

Inj, sutimlimab-jome, 10 mg

Injection, sutimlimab-jome, 10 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Oct 1, 2022
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9444

MUE — Medically Unlikely Edits

Maximum units of J1302 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 770
Outpatient Hospital 770
Practitioner Services 770

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
55292-0820-01 Enjaymo
80203-0347-01 Enjaymo

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2022-Q4
    Inj, sutimlimab-jome, 10 mg